EQUITY RESEARCH MEMO

Whale Imaging

Generated 5/11/2026

Executive Summary

Conviction (model self-assessment)55/100

Whale Imaging is a San Diego-based medical device company developing the G-Arm®, a bi-plane X-ray imaging system designed to overcome the limitations of traditional C-arm devices in interventional radiology, surgery, and pain management. Founded in 2019, the company aims to improve procedural efficiency and image quality by providing simultaneous orthogonal views, potentially reducing procedure time and radiation exposure. While still in early stages (no disclosed funding or regulatory approvals), the G-Arm addresses a clear clinical need for better intraoperative imaging. The company's success hinges on achieving regulatory clearance (FDA 510(k) or similar) and establishing clinical utility. Given the competitive landscape of established C-arm manufacturers, Whale Imaging must differentiate through clinical evidence and partnerships. Near-term catalysts include regulatory submissions, initial clinical data, and strategic collaborations.

Upcoming Catalysts (preview)

  • Q3 2026FDA 510(k) Clearance or CE Mark Submission40% success
  • Q1 2027First Clinical Study Results50% success
  • Q2 2027Strategic Partnership or Distribution Agreement30% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)